| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PD-0332991 | CCLE | pan-cancer | AAC | -0.089 | 0.07 |
| mRNA | Camptothecin | GDSC1000 | pan-cancer | AAC | -0.063 | 0.07 |
| mRNA | parbendazole | CTRPv2 | pan-cancer | AAC | -0.058 | 0.07 |
| mRNA | Crizotinib | CTRPv2 | pan-cancer | AAC | -0.061 | 0.07 |
| mRNA | isoevodiamine | CTRPv2 | pan-cancer | AAC | -0.061 | 0.07 |
| mRNA | VNLG/124 | GDSC1000 | pan-cancer | AAC | -0.06 | 0.07 |
| mRNA | Vinorelbine | GDSC1000 | pan-cancer | AAC | 0.066 | 0.07 |
| mRNA | SGC0946 | GDSC1000 | pan-cancer | AAC | -0.065 | 0.07 |
| mRNA | nakiterpiosin | CTRPv2 | pan-cancer | AAC | -0.062 | 0.07 |
| mRNA | PRIMA-1-Met | CTRPv2 | pan-cancer | AAC | -0.096 | 0.07 |